Concepedia
Statistics
Publications
17
Citations
2.9K
H-Index
15
Active since
2000
Affiliations
University of Oxford(Current)
University of Nottingham
University of Birmingham
Queen Elizabeth Hospital Birmingham
University of Bristol
Mathis Heydtmann is an author at University of Oxford specializing in medicine, pharmacotherapy, and liver disease.
Publications per year
2000–2024
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
James Neuberger, Jai V. Patel, Helen Caldwell et al. · Gut · 2020 · 426 citations · Full text
Medicine, Pathology, Radiology +16
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients
Juan Carlos García‐Pagán, Mathis Heydtmann, S. Raffa et al. · Gastroenterology · 2008 · 353 citations
Medicine, Neurology, Pulmonology +3
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
1–5 of 17